Ayse Ӧzatılgan

956 citations
21 papers · 495 indexed · 1 hit paper · h-index 8
Topics
Prostate Cancer Treatment and Research (21 papers)Radiopharmaceutical Chemistry and Applications (8 papers)Multiple Myeloma Research and Treatments (6 papers)

In The Last Decade

Ayse Ӧzatılgan

19 papers receiving 493 citations

Hit Papers

Cabazitaxel versus Abiraterone or Enzalutamide in Metasta...20192026202120232019100200300

Peers

Ayse Ӧzatılgan
Comparison fields: 5 of 45
  • Pulmonary and Respiratory Medicine 442
  • Oncology 176
  • Radiology, Nuclear Medicine and Imaging 172
  • Cancer Research 148
  • Molecular Biology 81
Replace John Bernard with:
John Bernard France
R. Nevin Murray Canada
Grace Shaw United States
Gal Maier United Kingdom
Katherine Sunderland Canada
E. Ileana France
Ines Figueiredo United Kingdom
Alexis K. Smith United States
Ruth Riisnaes United Kingdom
Mai N. Van Netherlands
Ayse Ӧzatılgan relative to John Bernard France John Bernard's profile →
Citations per field
00.5×1.5×2.3×
John Bernard · 1×
Citations per year

Countries citing papers authored by Ayse Ӧzatılgan

Since Specialization
Citations

This map shows the geographic impact of Ayse Ӧzatılgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayse Ӧzatılgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayse Ӧzatılgan more than expected).

Fields of papers citing papers by Ayse Ӧzatılgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayse Ӧzatılgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayse Ӧzatılgan. The network helps show where Ayse Ӧzatılgan may publish in the future.

Co-authorship network of co-authors of Ayse Ӧzatılgan

This figure shows the co-authorship network connecting the top 25 collaborators of Ayse Ӧzatılgan. A scholar is included among the top collaborators of Ayse Ӧzatılgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayse Ӧzatılgan. Ayse Ӧzatılgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 7
3 2
4 16
5 17
6 6
7 3
8 2
9 4
10 0
11 1
12 2
13 1
14 0
15 4
16
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancerbreakdown →
377
17 9
18 1
19 21
20 14

About Ayse Ӧzatılgan

Ayse Ӧzatılgan is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Cancer Research, having authored 21 papers that have together received 495 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (442 citations), Cancer Research (148 citations) and Radiology, Nuclear Medicine and Imaging (172 citations). Ayse Ӧzatılgan has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Johann S. de Bono, Ronald de Wit, Karim Fizazi, Joan Carles, Carole Hélissey, Christian Wülfing, Gero Kramer, Roberto Iacovelli, Daniel Castellano and Christine Théodore. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026